Triple-Negative Breast Cancer (TNBC) Terminated Phase 2 Trials for Anastrozole (DB01217)

Also known as: Triple-negative Breast Cancer

IndicationStatusPhase
DBCOND0067309 (Triple-Negative Breast Cancer (TNBC))Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01234532Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by SurgeryTreatment